Dermata Therapeutics Inc. (DRMA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Dermata Therapeutics Inc.

    NASDAQ: DRMA · Real-Time Price · USD
    5.46
    -0.04 (-0.73%)
    At close: Sep 11, 2025, 3:59 PM
    5.40
    -1.10%
    After-hours: Sep 11, 2025, 07:57 PM EDT

    Dermata Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -12.29M -7.79M -9.61M -7.9M
    Depreciation & Amortization
    		 n/a n/a n/a 14.13K
    Stock-Based Compensation
    		 657.65K 522.08K 930.33K 1.91M
    Other Working Capital
    		 575.38K 494.35K -135.03K -121.42K
    Other Non-Cash Items
    		 n/a n/a n/a n/a
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 466.86K 863.68K -153.58K 289.55K
    Operating Cash Flow
    		 -11.16M -6.41M -8.83M -5.69M
    Capital Expenditures
    		 n/a n/a 4.00 n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a
    Debt Repayment
    		 n/a n/a n/a 1.01M
    Common Stock Repurchased
    		 -828 -40 n/a -1M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 1.11K 187.00 287.00 n/a
    Financial Cash Flow
    		 6.89M 7.61M 4.28M 15.96M
    Net Cash Flow
    		 -4.28M 1.2M -4.56M 10.27M
    Free Cash Flow
    		 -11.16M -6.41M -8.83M -5.69M

    Add to Watchlist